Table 4.
Associations of HIV status and MGUS in Eswatini
| HIV-positive participants | MGUS positive (n = 27), No. (%) | MGUS negative (n = 172), No. (%) | Univariable odds ratio (95% CI) | P | Adjusted a odds ratio (95% CI) | Adjusted P |
|---|---|---|---|---|---|---|
| CD4 > 500/mL | 12 (44.4) | 107 (62.2) | 0.84 (0.17 to 4.13) | .83 | 0.89 (0.17 to 4.69) | .89 |
| CD4 200-500/mL | 13 (48.1) | 50 (29.1) | 1.95 (0.40 to 9.6) | .41 | 1.68 (0.32 to 8.82) | .54 |
| CD4 < 200/mL | 2 (7.4) | 15 (8.7) | (Referent) | — | (Referent) | — |
| On ART | 18 (66.7) | 146 (84.9) | 0.36 (0.13 to 1.06) | .04 | 0.31 (0.11 to 0.82) | .02 |
| Not on ART | 8 (29.6) | 23 (13.4) | (Referent) | — | (Referent) | — |
| Data missing | 1 (3.7) | 3 (1.7) | — | — | — | — |
| Viral load suppressed (<1000/mL) | 20 (74.1) | 144 (83.7) | 0.56 (0.20 to 1.71) | .27 | 0.46 (0.17 to 1.24) | .13 |
| Viral load not suppressed | 7 (25.9) | 28 (16.3) | (Referent) | — | (Referent) | — |
a
Adjusted for age, sex, and wealth quintile. ART = antiretroviral therapy; CI = confidence interval; MGUS = monoclonal gammopathy of undetermined significance.